In the context of EGFR inhibition in a wild-type KRAS colorectal cancer cell line we show that a lack of TK1 attenuation, and thus similar [18F]-FLT PET, in treated xenografts reflected PI3K-mTOR activity. Here, KRAS is linked to colorectal cancer.